Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $48.42 | 2 | 52.5% |
| Education | $43.89 | 3 | 47.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $43.89 | 3 | $0 (2018) |
| Boston Scientific Corporation | $25.34 | 1 | $0 (2022) |
| Axonics, Inc. | $23.08 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $23.08 | 1 | Axonics, Inc. ($23.08) |
| 2022 | $25.34 | 1 | Boston Scientific Corporation ($25.34) |
| 2018 | $43.89 | 3 | PFIZER INC. ($43.89) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/28/2023 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Urology | ||||||
| 11/09/2022 | Boston Scientific Corporation | rezum Generator (Device) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: rezum_URO | ||||||
| 11/20/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 09/10/2018 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,455 | 1,828 | $303,332 | $81,372 |
| 2022 | 12 | 1,584 | 1,839 | $269,267 | $70,730 |
| 2021 | 10 | 1,447 | 1,696 | $282,183 | $80,247 |
| 2020 | 10 | 1,342 | 1,530 | $252,842 | $63,281 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 415 | 550 | $140,572 | $34,131 | 24.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 79 | 115 | $68,606 | $20,841 | 30.4% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 13 | 102 | $14,790 | $11,463 | 77.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 143 | 153 | $23,010 | $6,048 | 26.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 275 | 310 | $18,530 | $2,389 | 12.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 35 | 35 | $8,134 | $1,941 | 23.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $7,680 | $1,704 | 22.2% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 12 | 12 | $7,124 | $1,044 | 14.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 361 | 424 | $8,480 | $932.80 | 11.0% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 11 | 11 | $1,749 | $247.70 | 14.2% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 11 | 11 | $2,750 | $235.95 | 8.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 63 | 64 | $768.00 | $218.24 | 28.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 17 | $1,139 | $176.40 | 15.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 309 | 363 | $82,383 | $21,593 | 26.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 80 | 108 | $57,672 | $20,060 | 34.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 226 | 257 | $35,930 | $9,848 | 27.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 71 | 71 | $22,720 | $5,788 | 25.5% |
| 52234 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | Facility | 2022 | 11 | 13 | $8,255 | $2,636 | 31.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 47 | 47 | $10,434 | $2,593 | 24.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 291 | 323 | $16,473 | $2,399 | 14.6% |
| 55700 | Biopsy of prostate gland | Facility | 2022 | 20 | 20 | $11,360 | $2,155 | 19.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 12 | $4,160 | $1,298 | 31.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 477 | 585 | $11,700 | $1,297 | 11.1% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2022 | 20 | 20 | $5,000 | $546.84 | 10.9% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2022 | 20 | 20 | $3,180 | $515.20 | 16.2% |
About Dr. Robert Cherry, MD
Dr. Robert Cherry, MD is a Urology healthcare provider based in Charlton, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1821073982.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Cherry, MD has received a total of $92.31 in payments from pharmaceutical and medical device companies, with $23.08 received in 2023. These payments were reported across 5 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($48.42).
As a Medicare-enrolled provider, Cherry has provided services to 5,828 Medicare beneficiaries, totaling 6,893 services with total Medicare billing of $295,630. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Charlton, MA
- Active Since 12/13/2005
- Last Updated 03/05/2015
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1821073982
Products in Payments
- XTANDI (Drug) $43.89
- rezum Generator (Device) $25.34
- Axonics (Device) $23.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.